Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02258646
Other study ID # 228919/DHE
Secondary ID HST1117-13HST111
Status Completed
Phase N/A
First received
Last updated
Start date October 2014
Est. completion date December 2018

Study information

Verified date April 2019
Source University Hospital of North Norway
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research project aims to conduct a three-arm multi-center randomized controlled trial (RCT) on an innovative telerehabilitation intervention for patients with chronic obstructive pulmonary disease (COPD). The overall purpose of the RCT is to demonstrate whether long-term integrated telerehabilitation involving exercise training at home, telemonitoring, and education/self-management will prevent hospital readmissions, thus reducing healthcare costs, for patients with COPD, and will improve patient status and quality of life.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date December 2018
Est. primary completion date December 2018
Accepts healthy volunteers No
Gender All
Age group 40 Years to 80 Years
Eligibility Inclusion Criteria:

- Diagnosis of COPD

- At least one COPD-related hospitalization or COPD-related emergency department presentation in the previous 12 months to enrollment

- Capable to provide signed written informed consent

Exclusion Criteria:

- Attendance to a rehabilitation program in the previous 6 months of enrollment

- Participation in another study that may have an impact on the outcome of this study

- Deemed by the health care team to be physically uncapable to perform the study procedures

- Presence of comorbidities wich might prevent the patient from safely undertake an exercise program at home

- Home environment not suitable for installation and use of rehabilitation and monitoring equipment (e.g. physical space, Wi-FI Internet or mobile Internet via 4G)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Exercise training at home

Telemonitoring and education/self-management


Locations

Country Name City State
Australia The Alfred Melbourne Victoria
Denmark Sydvestjysk Hospital Esbjerg
Norway University Hospital of North Norway Tromsø

Sponsors (10)

Lead Sponsor Collaborator
University Hospital of North Norway Aalborg University, Esbjerg Municipality, La Trobe University, LHL Helse, Sydvestjysk Hospital, The Alfred, The Research Council of Norway, The Royal Norwegian Ministry of Health, University of Tromso

Countries where clinical trial is conducted

Australia,  Denmark,  Norway, 

Outcome

Type Measure Description Time frame Safety issue
Other Change from baseline in BODE Index at 6 months 6 months
Other Change from baseline in BODE Index at 1 year 1 year
Other Change from baseline in BODE Index at 2 years 2 years
Primary Combined number of hospitalizations and emergency department presentations Two years
Secondary Hospitalizations Two years
Secondary Emergency department presentations Two years
Secondary Mortality Two years
Secondary Time free from first hospitalization or emergency department presentation Two years
Secondary Cost-effectiveness Cost-Utility Analysis (Cost/QALY) Two years
Secondary Change from baseline in COPD Assessment Test at 6 months 6 months
Secondary Change from baseline in COPD Assessment Test at 1 year One year
Secondary Change from baseline in COPD Assessment Test at 2 years Two years
Secondary Change from baseline in EQ-5D at 6 months Six months
Secondary Change from baseline in EQ-5D at 1 year One year
Secondary Change from baseline in EQ-5D at 2 years Two years
Secondary Change from baseline in Hospital Anxiety and Depression Scale at 6 months Six months
Secondary Change from baseline in Hospital Anxiety and Depression Scale at 1 year One Year
Secondary Change from baseline in Hospital Anxiety and Depression Scale at 2 years Two years
Secondary Change from baseline in Generalized Self-Efficacy Scale at 6 months Six months
Secondary Change from baseline in Generalized Self-Efficacy Scale at 1 year One year
Secondary Change from baseline in Generalized Self-Efficacy Scale at 2 years Two years
Secondary Change from baseline in 6- minute walking distance at 6 months Six months
Secondary Change from baseline in 6- minute walking distance at 1 year One year
Secondary Change from baseline in 6- minute walking distance at 2 years Two years
Secondary Change from baseline in physical activity at 6 months Six months
Secondary Change from baseline in physical activity at 1 year One year
Secondary Change from baseline in physical activity at 2 years Two years
Secondary Patient Global Impression of Change after 2 years Two years
Secondary Hospitalizations at 1 year One year
Secondary Emergency department presentations at 1 year One year
Secondary Mortality at 1 year One year
See also
  Status Clinical Trial Phase
Completed NCT05043428 - The Roles of Peers and Functional Tasks in Enhancing Exercise Training for Adults With COPD N/A
Completed NCT00528996 - An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler. Phase 2
Completed NCT03740373 - A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate Phase 1
Completed NCT05393245 - Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data
Completed NCT05402020 - Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
Completed NCT04011735 - Re-usable Respimat® Soft MistTM Inhaler Study
Enrolling by invitation NCT03075709 - The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan
Completed NCT03764163 - Image and Model Based Analysis of Lung Disease Early Phase 1
Completed NCT00515268 - Endotoxin Challenge Study For Healthy Men and Women Phase 1
Completed NCT04085302 - TARA Working Prototype Engagement Evaluation: Feasibility Study N/A
Completed NCT03691324 - Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study N/A
Completed NCT02236611 - A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT00153075 - Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT01009463 - A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT01017952 - A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT04882124 - Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD Phase 2
Completed NCT02853123 - Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients Phase 4
Completed NCT02619357 - Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma Phase 1
Recruiting NCT05858463 - High Intensity Interval Training and Muscle Adaptations During PR N/A
Not yet recruiting NCT05032898 - Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II

External Links